NorthCrest Asset Manangement’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.2M Buy
40,344
+1,933
+5% +$928K 0.54% 42
2026
Q1
$18.9M Sell
38,411
-14,024
-27% -$7.61M 0.59% 39
2025
Q4
$32M Sell
52,435
-1,033
-2% -$584K 0.72% 31
2025
Q3
$28.8M Sell
53,468
-349
-0.6% -$162K 0.69% 32
2025
Q2
$23.1M Sell
53,817
-68
-0.1% -$28.4K 0.62% 43
2025
Q1
$26.8M Buy
53,885
+1,354
+3% +$733K 0.81% 32
2024
Q4
$27.3M Buy
52,531
+474
+0.9% +$261K 0.82% 27
2024
Q3
$32.2M Buy
52,057
+899
+2% +$532K 0.97% 21
2024
Q2
$28.3M Buy
51,158
+832
+2% +$477K 0.94% 22
2024
Q1
$29.2M Buy
50,326
+480
+1% +$269K 1% 20
2023
Q4
$26.5M Sell
49,846
-2,495
-5% -$1.21M 1% 19
2023
Q3
$26.5M Sell
52,341
-240
-0.5% -$128K 1.08% 17
2023
Q2
$27.4M Sell
52,581
-242
-0.5% -$131K 1.09% 17
2023
Q1
$30.4M Sell
52,823
-1,392
-3% -$785K 1.27% 10
2022
Q4
$29.9M Sell
54,215
-1,470
-3% -$779K 1.7% 8
2022
Q3
$28.2M Buy
55,685
+943
+2% +$528K 1.53% 6
2022
Q2
$29.7M Sell
54,742
-598
-1% -$329K 1.52% 5
2022
Q1
$32.7M Buy
55,340
+859
+2% +$493K 1.55% 6
2021
Q4
$36.4M Buy
+54,481
New +$34M 2% 4

Other funds holding TMO

NorthCrest Asset Manangement's TMO Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Thermo Fisher Scientific (TMO) stake by 5% in Q2 2026, buying an estimated $928K and bringing the position to 40,344 shares worth $21.2M. The position accounts for 0.54% of the portfolio, ranked #42.

NorthCrest Asset Manangement first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $36.4M in Q4 2021. 1,102 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • NorthCrest Asset Manangement held 40,344 shares of Thermo Fisher Scientific worth $21.2M as of Q2 2026.
  • NorthCrest Asset Manangement bought 1,933 Thermo Fisher Scientific shares in Q2 2026, an estimated $928K.
  • Thermo Fisher Scientific made up 0.54% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #42 holding.
  • NorthCrest Asset Manangement first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • NorthCrest Asset Manangement's Thermo Fisher Scientific position peaked at $36.4M in Q4 2021.
  • 1,102 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.